Biopsy Devices Market Global Report by Product (Needle-Based Guns, Guidance Systems, Needles, Forceps, Others), Application (Breast, Lung, Prostate, Liver, Gastroenterology), Technology (CT Scan, Stereotactic, Ultrasound, MRI), End-User (Hospitals, Diagnostic & Imaging Center), Countries and Company Analysis 2025-2033

Furthermore, the increase in the geriatric population is another important factor driving the growth of biopsy devices. According to WHO data released in 2021, the number of people in the world who are 60 years of age or older is expected to double from 12–22% between 2015 and 2050, reaching 2.1 billion by that time. Furthermore, one in six people on the planet will be 60 years of age or older by 2030. Between 2020 and 2050, the population of people 80 years of age or older is predicted to treble, reaching 426 million. Furthermore, the likelihood of developing diseases including cancer, infections, autoimmune disorders, and inflammatory diseases also rises with age.

Growth Drivers for the Biopsy Devices Market

Quick Developments in Technology

Biopsy device innovations are still another significant aspect driving increase. Biopsy techniques are becoming safer, faster, and more effective because to technological improvements. For example, tissue samples can be extracted more quickly and comfortably with vacuum-assisted biopsy equipment, improving the patient experience. Harpera is a minimally invasive skin microbiopsy device that was licensed by Trajan Scientific and Medical from the University of Queensland. For skin problems, the gadget seeks to offer a more regular and less invasive skin sampling option. Furthermore, combining real-time imaging methods like MRI, CT, or ultrasound with biopsy equipment gives doctors a more precise target region, which lowers procedural risks and improves diagnostic accuracy.

For example, the University of Columbia engineering team unveiled MediSCAPE, a novel device that eliminates the need for biopsies by taking pictures of a living person's mouth tissues.

Large-scale investments in healthcare facilities

The industry is also growing as a result of increased investments in healthcare infrastructure, particularly in emerging markets. Modernizing medical facilities, including diagnostic labs and purchasing cutting-edge medical technology, is made easier by the increased funding from both public and private organizations. For example, the Biden-Harris Administration has proposed a $9.683 billion budget for the Centers for Disease Control and Prevention (CDC) in the President's Budget for Fiscal Year 2025.

This budget request, which is $499.2 million higher than the FY 2023 appropriation, will support young families for the children's wellbeing, enable the CDC respond quickly to health hazards, and address overdose and mental health emergencies. The use of sophisticated biopsy equipment is a logical next step as healthcare systems around the world concentrate on providing faster and more accurate diagnosis. This has increased the market for these devices and given patients greater access to high-quality diagnostic treatments, which bodes well for the expansion of the biopsy device market.

Growing Cancer Incidence

The market for autopsy instruments is significantly influenced by the rising incidence of cancer worldwide. Biopsies are a crucial diagnostic tool for cancer diagnosis since accurate and early-stage identification is necessary for the best possible treatment. The World Health Organization (WHO) estimates that cancer killed 9.6 million people in 2018, making it the second most common cause of death worldwide. The necessity for precise and effective diagnostic techniques has increased as cancer rates continue to grow. As a result, biopsy tools are increasingly essential for detecting cancerous tissues so that medical professionals can create effective treatment strategies. The market growth for biopsy equipment is favorably impacted by the increased demand for sophisticated biopsy instruments, which is fueled by the rising prevalence of cancer.

Challenges in the Biopsy Device Market

Training and Skill Gaps

The market for biopsy devices is severely hampered by training and skill deficits, especially in poor nations. To function properly, advanced biopsy devices—such as those that need robotic help or image guidance (CT, MRI, or ultrasound)—need specific technical know-how. Healthcare workers may find it challenging to use this sophisticated technology in areas with little access to training and educational materials, which could result in uneven utilization and lower acceptance rates. Since incorrect handling of biopsy equipment may lead to problems or erroneous results, this skill gap may have an effect on patient outcomes and diagnostic accuracy. Expanded training programs, cooperation with global medical organizations, and improved integration of educational materials into healthcare systems are required to get past this obstacle and guarantee appropriate device use while optimizing the potential of cutting-edge biopsy technologies.

Competition from Alternative Diagnostics

The market for conventional biopsy instruments is seeing increasing competition from non-invasive diagnostic procedures, especially liquid biopsy. Compared to tissue-based biopsy techniques, liquid biopsy provides a less intrusive, faster, and more economical option by analyzing biomarkers in blood or other body fluids. These non-invasive techniques offer major benefits for early identification and surveillance since they may sensitively identify genomic changes, cancer-related mutations, and other disease markers. The market for conventional biopsy devices is anticipated to decline as liquid biopsy technology becomes more widely available and receives additional regulatory clearances. The market may face competition if the increased desire for non-invasive diagnostics slows the use and expansion of conventional biopsy methods.

In the market for biopsy instruments, biopsy needles are essential

Biopsy needles are among the crucial products in the global biopsy device market. This is due to their vital role in tissue sample extraction for diagnostic purposes. These needles enable minimally invasive techniques, lowering patient discomfort and restoration time. With the increasing incidence of diseases, which includes cancer, the need for correct and well-timed analysis is growing, propelling the want for biopsy devices. Biopsy needles provide precision and reliability, permitting healthcare experts to gain high-quality tissue samples for histological examination, guiding remedy choices, and improving patient outcomes.

Breast biopsy holds a significant share of the global autopsy market

Breast biopsy holds one of the most significant shares in the biopsy devices market. This is due to its significance in breast cancer diagnosis. According to breastcancer.org, in 2023, a predicted 297,790 new instances of invasive breast cancers are expected to be diagnosed in U.S. women. With breast cancer being one of the most common conventional cancers globally, the demand for correct and minimally invasive diagnostic techniques is high. Breast biopsy devices enable the extraction of tissue samples from suspicious breast lesions, facilitating early detection and treatment planning. Moreover, improvements in breast test technologies, such as vacuum-assisted and stereotactic biopsies, enhance diagnostic accuracy and patient consolation, similarly driving autopsy devices market dominance.

CT scan technology is widely used for global biopsy procedures

CT scan technology is among the widely utilized technologies in the global biopsy devices market. This is because of its precision and versatility. CT-guided biopsies provide real-time imaging guidance, permitting healthcare experts to accurately target and extract tissue samples from particular areas of the subject. This technology enhances diagnostic accuracy, in particular in deep-seated or complex lesions. Also, CT scans offer specified anatomical facts, aiding remedy planning and tracking. With their excellent availability and effectiveness, CT-guided biopsies remain a cornerstone in the biopsy device market.

Hospitals will dominate the biopsy instruments market due to increasing demand

Hospitals may command an extensive share of the biopsy devices market. This is due to their function as primary healthcare companies and centers for diagnostic approaches. Hospitals frequently have specialized departments prepared with superior imaging technologies and skilled healthcare professionals capable of acting biopsies. Further, hospitals manage a vast range of scientific conditions, growing the need for biopsy devices across diverse specialties and departments.

Biopsy Devices Market Overview by Regions

By country, the biopsy devices market is split into North America (United States, Canada), Europe (France, Germany, Italy, Spain, United Kingdom, Belgium, the Netherlands, and Turkey), Asia Pacific (China, Japan, India, Australia, South Korea, Thailand, Malaysia, Indonesia, and New Zealand), Latin America (Brazil, Mexico, and Argentina), Middle East & Africa (South Africa, Saudi Arabia, and the United Arab Emirates). The United States held a leading share of the global biopsy devices market. This is due to established market participants domiciled in the area. 

United States Biopsy Devices Market

The market for autopsy instruments in the US is among the biggest in the world, driven by growing desire for minimally invasive procedures, higher cancer incidence, and medical technology improvements. The aging population, increased awareness of early disease detection, and rising healthcare spending are some of the major drivers driving market expansion. Lung, prostate, and breast cancers are the main causes of biopsy operations, and the market is dominated by technologies such as MRI-guided biopsies, CT scans, and ultrasounds. Furthermore, advancements in liquid biopsy and robotic-assisted test equipment are increasing the range of available treatments and improving the precision of diagnosis. The United States is a key player in the worldwide biopsy devices market, providing development and investment potential due to the presence of top medical device manufacturers and a robust healthcare infrastructure.

The National Cancer Institute estimates that 2,001,140 new cases of cancer will be detected in the United States in 2024. It is anticipated that the country's growing cancer rate, together with a robust healthcare and regulatory framework that encourages the creation of cutting-edge medical technology, will propel market expansion.

Germany Necropsy Devices Market

Due to rising cancer rates, high healthcare standards, and an aging population, Germany's biopsy instrument industry is a significant sector of the European healthcare system. The nation is renowned for its cutting-edge medical technology and a strong healthcare system, both of which encourage the broad use of necropsy instruments. Many biopsy procedures, such as core needle biopsy, fine-needle aspiration, and image-guided biopsies utilizing CT or ultrasound, are in high demand due to the increased emphasis on early cancer detection, particularly for breast, prostate, and colorectal cancers. Furthermore, Germany's strong medical device R&D efforts encourage innovation in fields like robotically assisted and minimally invasive biopsy methods. The market's growth in Germany is also aided by government financing for healthcare and rising patient awareness.

India Necropsy Devices Market

The market for biopsy instruments in India is growing quickly because to factors such rising healthcare awareness, medical technology developments, and an increase in the prevalence of cancer. The need for diagnostic instruments including needle biopsies, core biopsies, and image-guided biopsy procedures is being driven by the rising incidence of cancer in the nation, especially breast, cervical, and oral cancers. Additionally, because of their increased precision and shortened recovery periods, minimally invasive procedures like CT-guided biopsies and ultrasonography are becoming more and more popular. The market is growing as a result of India's developing healthcare system and rising investments in medical technology. Regional healthcare inequities, high device costs, and a shortage of qualified specialists are still issues, nevertheless. India's market for biopsy equipment is expected to increase significantly despite these obstacles because of the country's sizable population and rising healthcare demands.

The market for biopsy devices in India is anticipated to expand dramatically as a result of increased efforts by both public and private entities to speed up cancer diagnosis and treatment as well as the growth of the nation's healthcare system. For example, the MR Fusion Biopsy equipment, the first of its kind in Maharashtra, India, was installed at Sir H.N. Reliance Foundation Hospital in July 2024. It is anticipated that the action will improve cancer care nationwide and spur additional market expansion.

Saudi Arabia Biopsy Devices Market

Because of rising healthcare spending, rising cancer rates, and government initiatives to improve medical infrastructure, the Saudi Arabian market for biopsy instruments is developing. The need for biopsy operations is being driven by an increase in the number of instances of colorectal, breast, and prostate cancers as well as a greater emphasis on early diagnosis and preventative healthcare. Healthcare facilities in Saudi Arabia are increasingly using cutting-edge technologies, such as biopsy instruments that are guided by ultrasound, CT, and MRI. The nation's Vision 2030 program, which prioritizes advancing medical innovation and enhancing healthcare services, is also helping the industry expand. Advanced biopsy technology adoption in the area is further accelerated by rising middle-class healthcare aspirations and increased knowledge of cancer and other disorders.

Product – Market breakup in 5 viewpoints:

1.    Needle-Based Guns
2.    Biopsy Guidance Systems
3.    Biopsy Needles
4.    Biopsy Forceps
5.    Others

Application – Market breakup in 6 viewpoints:

1.    Breast Biopsy
2.    Lung Biopsy
3.    Prostate Biopsy
4.    Liver Biopsy
5.    Gastroenterology Biopsy
6.    Others

Technology – Market breakup in 5 viewpoints:

1.    CT Scan
2.    Stereotactic Guided
3.    Ultrasound Guided
4.    MRI Guided
5.    Others

End-User – Market breakup in 3 viewpoints:

1.    Hospitals
2.    Diagnostic & Imaging Center
3.    Others

Country – Market of 25 Countries Covered in the Report:

1.    North America

1.1    United States
1.2    Canada

2.    Europe

2.1    France
2.2    Germany
2.3    Italy
2.4    Spain
2.5    United Kingdom
2.6    Belgium
2.7    Netherland
2.8    Turkey

3.    Asia Pacific

3.1    China
3.2    Japan
3.3    India
3.4    South Korea
3.5    Thailand
3.6    Malaysia
3.7    Indonesia
3.8    Australia
3.9    New Zealand

4.    Latin America

4.1    Brazil
4.2    Mexico
4.3    Argentina

5.    Middle East & Africa

5.1    Saudi Arabia
5.2    UAE
5.3    South Africa

All the Key players have been covered from 3 Viewpoints:

•    Overview
•    Recent Development
•    Revenue Analysis

Company Analysis:

1.    Cardinal Health, Inc.
2.    Hologic, Inc.
3.    Danaher Corporation
4.    Becton, Dickinson and Company
5.    Boston Scientific Corporation
6.    Medtronic plc.
7.    Olympus Corporation
8.    CONMED Corporation

Report Details: